(R)-3-ethylpiperidine | 45582-61-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (R)-3-ethylpiperidine
• 英文别名: (3R)-3-Ethylpiperidine
• CAS: 45582-61-4
• 化学式: C₇H₁₅N
• 分子量: 113.203
• InChiKey: YLUDSYGJHAQGOD-SSDOTTSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,3-二氯吡啶-5-羰酰氯 、 (R)-3-ethylpiperidine 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 生成
  参考文献：
  名称：

  Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity

  摘要：

  High throughput screening led to the identification of nicotinamide derivative 2 as a structurally novel mGluR5 antagonist. Optimization of the modular scaffold led to the discovery of 16m, a compound with high affinity for mGluR5 and excellent selectivity over other glutamate receptors. Compound 16m exhibits a favorable PK profile in rats, robust anxiolytic-like effects in three different animal models of fear and anxiety, as well as a good PK/PD correlation. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.11.001
• 作为产物：
  描述：

  N-phenylselenopropyl-2-(1'-propenyl)-perhydro-1,3-benzoxazine 在 lithium aluminium tetrahydride 、 三氯化铝 、 偶氮二异丁腈 、 三正丁基氢锡 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 、 苯 为溶剂， 反应 0.25h， 生成 (R)-3-ethylpiperidine
  参考文献：
  名称：

  Regio- and stereoselective 6- exo - trig radical cyclisations onto chiral perhydro-1,3-benzoxazines: synthesis of enantiopure 3-alkylpiperidines

  摘要：

  Enantiopure 3-alkyl substituted piperidines are prepared by diastereoselective 6-exo-trig cyclisation of perhydro-1,3-benzoxazines derived from (-)-(8)-amino menthol. The diastereoselective cyclisation is promoted by tributyltin hydride, and the competitive 1,5-hydrogen migration depends on the position of the acceptor double bond and the radical site. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(00)00230-5

文献信息

• HPK1 ANTAGONISTS AND USES THEREOF
  申请人：Nimbus Saturn, Inc.

  公开号：US20210078996A1

  公开（公告）日：2021-03-18

  The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.

  本发明提供了化合物、其组合物以及使用这些化合物用于抑制HPK1和治疗HPK1介导的疾病的方法。
• [EN] SPIRO CYCLOPENTANE COMPOUNDS USEFUL AS ANTAGONISTS OF THE H1-RECEPTOR<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：GLAXO GROUP LTD

  公开号：WO2009016084A1

  公开（公告）日：2009-02-05

  This invention relates to novel spiro cyclopentane derivatives of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders.

  该发明涉及公式（I）的新颖螺环戊烷衍生物或其药用盐，用于治疗中枢神经系统（CNS）的疾病和病症，特别是睡眠障碍。
• 7-AZAINDOLE OR 4,7-DIAZAINDOLE DERIVATIVES AS IKK EPSILON AND TBK1 INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  申请人：GREEN CROSS CORPORATION

  公开号：US20160297815A1

  公开（公告）日：2016-10-13

  Provided are 7-azaindole or 4,7-diazaindole derivatives as an IKKε (I-kappa-B kinase epsilon) and TBK1 (TANK-binding kinase 1) inhibitor. The 7-azaindole or 4,7-diazaindole derivative effectively inhibits IKKε and TBK1, and thus is useful not only as an anticancer agent for the treatment of various cancers including colorectal cancer, breast cancer, CNS cancer, colon cancer, non-small cell lung cancer, kidney cancer, prostate cancer, ovarian cancer, uterus cancer, stomach cancer, liver cancer, skin cancer, lung cancer, brain cancer, bladder cancer, esophageal cancer, pancreatic cancer, thyroid cancer, head and neck cancer, squamous cell carcinoma, osteosarcoma, B-cell or T-cell lymphoma, acute or chronic leukemia and multiple myeloma, but as a therapeutic agent for chronic inflammation.

  提供了7-氮杂吲哚或4,7-二氮杂吲哚衍生物作为IKKε（I-卡帕B激酶ε）和TBK1（TANK结合激酶1）抑制剂。7-氮杂吲哚或4,7-二氮杂吲哚衍生物有效地抑制IKKε和TBK1，因此不仅可用作抗癌剂治疗各种癌症，包括结直肠癌、乳腺癌、中枢神经系统癌、结肠癌、非小细胞肺癌、肾癌、前列腺癌、卵巢癌、子宫癌、胃癌、肝癌、皮肤癌、肺癌、脑癌、膀胱癌、食管癌、胰腺癌、甲状腺癌、头颈癌、鳞状细胞癌、骨肉瘤、B细胞或T细胞淋巴瘤、急性或慢性白血病和多发性骨髓瘤，还可作为慢性炎症的治疗剂。
• Novel Compounds
  申请人：Cheng Yun-Xing

  公开号：US20070259888A1

  公开（公告）日：2007-11-08

  Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R 1 , R 2 and R 3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

  公式I的化合物，或其药用盐：其中X、R1、R2和R3如规范中定义的那样，以及包括这些化合物的盐和药物组合物已经准备好。它们在治疗中很有用，特别是在疼痛管理中。
• Inhibition of <i>Plasmodium falciparum</i> Lysyl‐tRNA Synthetase via a Piperidine‐Ring Scaffold Inspired Cladosporin Analogues
  作者：Palak Babbar、Mizuki Sato、Yogavel Manickam、Siddhartha Mishra、Karl Harlos、Swati Gupta、Suhel Parvez、Haruhisa Kikuchi、Amit Sharma

  DOI：10.1002/cbic.202100212

  日期：2021.7.15

  cladosporin inhibitors against Plasmodium falciparum lysyl-tRNA synthetase (PfKRS). The series retains selectivity against its human counterpart but it was observed that replacing the tetrahydropyran moiety by piperidine reduces potency. Co-crystals of Cla−B and Cla−C with PfKRS reveal key interactions and loop readjustments that allow drug binding and inhibition of the enzyme.

  本研究重点是针对恶性疟原虫赖氨酰-tRNA 合成酶（ Pf KRS）的哌啶环启发枝孢菌素抑制剂的合成和结构分析。该系列保留了针对人类对应物的选择性，但观察到用哌啶取代四氢吡喃部分会降低效力。 Cla−B 和 Cla−C 与Pf KRS 的共晶揭示了关键的相互作用和环重新调整，从而允许药物结合和抑制酶。